Stephen Donaghy
Known title: CEOCIK: 0001492959
Stephen Donaghy's purchase track record
How the stock did after each of Stephen Donaghy's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since February 28, 2022
Stock higher 6 months later
100%
3 months: 67%
Median 6-month return
+65.0%
3 months: +14.5%
Beat the S&P 500
100%
median +51.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/6/2023 | UVE | $60K | +37.6% | +65.9% | +14.3% |
| 9/14/2022 | UVE | $116K | -15.7% | +65.0% | -1.4% |
| 2/28/2022 | UVE | $119K | +14.5% | +9.3% | -7.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| UVE | ▼ Sell | Tax Withholding | 6,286 | $215K | 3/30/2026 | View on chart |
| UVE | ▲ Buy | Option Exercise | 14,598 | $0 | 3/27/2026 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 5,745 | $193K | 3/27/2026 | View on chart |
| UVE | ▲ Buy | Option Exercise | 13,566 | $0 | 3/19/2026 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 5,339 | $176K | 3/19/2026 | View on chart |
| UVE | ▲ Buy | Grant | 47,919 | $0 | 2/24/2026 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 14,213 | $430K | 2/24/2026 | View on chart |
| UVE | ▼ Sell | Open Market | 25,000 | $844K | 12/30/2025 | View on chart |
| UVE | ▼ Sell | Open Market | 25,000 | $852K | 12/29/2025 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 6,286 | $149K | 3/31/2025 | View on chart |
| UVE | ▲ Buy | Option Exercise | 14,598 | $0 | 3/27/2025 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 5,745 | $131K | 3/27/2025 | View on chart |
| UVE | ▲ Buy | Grant | 61,526 | $0 | 2/21/2025 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 24,210 | $483K | 2/21/2025 | View on chart |
| UVE | ▼ Sell | Gift | 14,000 | $0 | 1/14/2025 | View on chart |
| UVE | ▼ Sell | Other | 15,973 | $318K | 4/1/2024 | View on chart |
| UVE | ▼ Sell | Gift | 2,000 | $0 | 1/16/2024 | View on chart |
| UVE | ▼ Sell | Gift | 9,000 | $0 | 1/12/2024 | View on chart |
| UVE | ▲ Buy | Open Market | 5,000 | $60K | 9/6/2023 | View on chart |
| UVE | ▲ Buy | Grant | 47,919 | $0 | 3/30/2023 | View on chart |
| UVE | ▼ Sell | Gift | 8,000 | $0 | 1/12/2023 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 6,314 | $65K | 1/3/2023 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 9,441 | $97K | 1/3/2023 | View on chart |
| UVE | ▲ Buy | Option Exercise | 16,000 | — | 1/3/2023 | View on chart |
| UVE | ▲ Buy | Open Market | 10,000 | $116K | 9/14/2022 | View on chart |
| UVE | ▼ Sell | Tax Withholding | 4,766 | $56K | 3/1/2022 | View on chart |
| UVE | ▲ Buy | Option Exercise | 17,000 | — | 3/1/2022 | View on chart |
| UVE | ▲ Buy | Open Market | 10,000 | $119K | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
UVE Hits 52‑Week High as Earnings Date Announced
Universal Insurance Holdings (UVE) has reached a 52‑week high, reflecting a recent rally in its share price. The company’s earnings guidance for Q3 2026 highlights a continued focus on investment income as underwriting remains volatile. Analysts note the stock’s low trailing P/E and modest dividend yield, while value investors assess whether the current price reflects its fundamentals. The upcoming earnings release will provide further insight into the company’s risk profile.
UVE Hits 52‑Week High as Earnings Date Announced. Universal Insurance Holdings (UVE) has reached a 52‑week high, reflecting a recent rally in its share price. The company’s earnings guidance for Q3 2026 highlights a continued focus on investment income as underwriting remains volatile. Analysts note the stock’s low trailing P/E and modest dividend yield, while value investors assess whether the current price reflects its fundamentals. The upcoming earnings release will provide further insight into the company’s risk profile.